Insider · CIK 0001925150

Duey Marc

Reports to the SEC for 1 company · DOYLESTOWN, PA

sec.gov

Transactions

Companies

Filings

CIK

0001925150

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-16	APREAprea Therapeutics, Inc.A Award	Director	AAward	+3,135 sh	—	—	259,290
2026-06-16	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+12.6K sh	—	—	12,555
2025-12-10	APREAprea Therapeutics, Inc. · Common WarrantP Purchase	Director	PPurchase	+21.5K sh	—	—	21,459
2025-12-10	APREAprea Therapeutics, Inc.P Purchase	Director	PPurchase	+21.5K sh	$1.17	+$25K	256,155
2025-06-05	APREAprea Therapeutics, Inc.A Award	Director	AAward	+1,045 sh	—	—	234,696
2025-06-05	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+4,185 sh	—	—	4,185
2024-10-18	APREAprea Therapeutics, Inc.S Sale	Director	SSale	−6,462 sh	$4.58	−$29.6K	233,651
2024-10-16	APREAprea Therapeutics, Inc.P Purchase	Director	PPurchase	+30K sh	$4.39	+$132K	240,113
2024-10-14	APREAprea Therapeutics, Inc.P Purchase	Director	PPurchase	+190 sh	$2.58	+$490.2	210,113
2024-06-20	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+4,185 sh	—	—	4,185
2024-06-20	APREAprea Therapeutics, Inc.A Award	Director	AAward	+1,045 sh	—	—	209,923
2023-08-23	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2023-08-23	APREAprea Therapeutics, Inc.A Award	Director	AAward	+500 sh	—	—	208,878
2022-08-23	APREAprea Therapeutics, Inc.C Conversion	Director	CConversion	+4.01M sh	—	—	4,167,589
2022-08-23	APREAprea Therapeutics, Inc.C Conversion	Director	CConversion	+11.6K sh	—	—	602
2022-08-23	APREAprea Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockC Conversion	Director	CConversion	−401K sh	—	—	0
2022-08-23	APREAprea Therapeutics, Inc. · Series A Non-Voting Convertible Preferred StockC Conversion	Director	CConversion	−1,161 sh	—	—	0
2022-07-28	APREAprea Therapeutics, Inc.A Award	Director	AAward	+5,995 sh	—	—	157,899
2022-07-28	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	Director	AAward	+29.6K sh	—	—	29,575

Recent filings

Accepted (ET)
Jun 174
Duey Marc0001104659-26-075280
SEC(opens sec.gov)
Dec 114
Duey Marc0001104659-25-120156
SEC(opens sec.gov)
Jun 94
Duey Marc0001104659-25-057809
SEC(opens sec.gov)
Oct 254
Duey Marc0001104659-24-111548
SEC(opens sec.gov)
Oct 174
Duey Marc0001104659-24-109386
SEC(opens sec.gov)
Oct 164
Duey Marc0001104659-24-108963
SEC(opens sec.gov)
Jun 214
Duey Marc0001104659-24-073932
SEC(opens sec.gov)
Aug 244
Duey Marc0001104659-23-095017
SEC(opens sec.gov)
Aug 14
Duey Marc0001104659-22-084762
SEC(opens sec.gov)

Companies

Aprea Therapeutics, Inc.DirectorAPRE

Address

3805 OLD EASTON ROAD

DOYLESTOWN, PA, 18902